Request Deal Involvement
HDL Therapeutics to go public via a SPAC merger with Swiftmerge Acquisition in a $480m deal.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Mayer Brown
legal advisors
Loeb & Loeb
or
Principals
target
HDL THERAPEUTICS INC
bidder
SWIFTMERGE ACQUISITION
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite